ArticleJournal of family medicine and primary care2025
Seroprevalence of SARS CoV 2 IgG in pandemic frontline healthcare workers.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The ongoing infection and transmission of the severe acute respiratory syndrome coronavirus 2019 (SARS-CoV2) has challenged the global health system in the recent past. However, currently, the infection rate has been substantially reduced, but the pandemic showed an inevitability to study the human response to the SARS-CoV2 infection. The core objective of this study is to determine the frequency of individuals in the healthcare workforce, who possess IgG antibodies specific to SARS-CoV-2. Methods: A cross-sectional study was conducted at tertiary care hospital of Maharashtra region. Total 300 Health care workers were including in the study. Their blood samples were tested for SARS-CoV-2 IgG antibody using Chemiluminescence methods. Results: The study was poised between male and female participants, with 47% and 53% of participants, respectively. The result showed 27% of seroprevalence, among the total participants, where 88% of seropositive participants were diagnosed with COVID-19 using RT-PCR techniques. The current study also illustrated the seroprevalence of the different classes of healthcare workers. Here, technicians and nurses showed a higher rate of seropositivity, 39.02% and 36.36%, respectively. Daily and close contacts with the COVID-19 patients were examined in relation to seropositivity. This study collected the RT-PCR results of the participants and used statistical tests to establish the association of RT-PCR results with seropositivity and symptoms (early and late). RT-PCR showed a significant relationship with early and late symptoms with a Conclusion: This study provides a framework that can be replicated in other communities. Overall, this study examined the seropositivity rate among the HCWs that could assist the hospital management in designing more effective COVID-19 appropriate guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.